2. Report on the workshop: "Clinical consequences of pathology and prognostic factors in aggressive NHL"

Ann Hematol. 2001:80 Suppl 3:B8-12. doi: 10.1007/pl00022797.
No abstract available

Publication types

  • Congress

MeSH terms

  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Case Management
  • Disease Progression
  • Humans
  • Lymphoma, B-Cell / mortality
  • Lymphoma, B-Cell / pathology
  • Lymphoma, Non-Hodgkin / classification
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoma, Non-Hodgkin / therapy
  • Lymphoma, T-Cell / mortality
  • Lymphoma, T-Cell / pathology
  • Prognosis
  • Risk Factors
  • Severity of Illness Index